Nirman Agri Genetics Approves Audited Financial Results for Year Ended March 31, 2026
Nirman Agri Genetics Limited announced that its Board of Directors, in a meeting held on May 30, 2026, considered and approved the audited standalone financial results and the annual statements for the year ended March 31, 2026. The company's financial reporting for the half-year ended and the year ended March 31, 2026, included an unmodified opinion from statutory auditors, M/s Devendra C. Belan and Associates Chartered Accountants.The board meeting confirmed the consideration of the audited standalone financial results for the half year/year ended March 31, 2026, along with the auditor's report. The company confirmed that the statutory auditors issued an audit report with an unmodified opinion on the audited financial results for the half and year ended March 31, 2026.
The company stated that it operates in a single reportable business segment, which is Agricultural Seeds.
Financial Performance Highlights
The audited standalone financial results provide a comprehensive view of the company's operations. The financial data, presented in Indian Rupees (Rs. In Lakhs), highlights key revenue and profitability metrics:| Particulars | 31/03/2026 (Half Year) | 30/09/2025 (Half Year) | 31/03/25 (Half Year) | 31/03/2026 (Year) | 31/03/25 (Year) |
|---|---|---|---|---|---|
| Total Income (I+II) | 5,034.44 | 14,622.88 | 12,407.18 | 19,657.32 | 23,670.20 |
| Total Expenses | 4,722.37 | 13,119.65 | 11,006.39 | 151.26* | 21,062.76 |
| Profit (Loss) For The Period | 302.64 | 1,457.90 | 1,365.00 | 1,760.53 | 2,528.60 |
| EPS (Basic) | 3.78 | N/A | 17.04 | 21.98 | 31.57 |
*Note: The total expenses for the year ended March 31, 2026, for the detailed table are derived from the provided figures (151.26 and 17,842.03 for two distinct lines).
Balance Sheet and Cash Flow Summary
The company's financial health was corroborated by the presentation of standalone assets and liabilities, as well as the statement of cash flows.Statement of Standalone Assets and Liabilities (Rs. in Lakhs)
| Particulars | Year Ended 31 March 2026 | Year Ended 31 March 2025 |
|---|---|---|
| TOTAL ASSETS | 12,935.34 | 11,307.67 |
| Non-Current Assets (Sub-Total) | 1,182.60 | 1,262.32 |
| Current Assets (Sub-Total) | 11,752.74 | 10,045.35 |
| TOTAL LIABILITIES | 12,935.33 | 11,307.67 |
| Shareholders' Funds (Sub-Total) | 12,754.68 | 10,994.15 |
| Current Liabilities (Sub-Total) | 180.65 | 313.52 |
Cash Flow Statement (Rs. in Lakhs)
| Particulars | 31 March 2026 | 31 March 2025 |
|---|---|---|
| Net Cash Flows from Operating Activities (A) | (2,449.66) | (3,136.80) |
| Net Cash Flows from Investing Activities (B) | 11.75 | 936.35 |
| Net Cash Flows from Financing Activities (C) | (54.76) | 4,632.09 |
| Net Increase/(Decrease) in Cash & Cash Equivalents | (2,492.66) | 2,431.64 |
| Cash &Cash Equivalents at the end of the year | 94.51 | 2,587.17 |
During the reporting period, the company recorded a net cash outflow from operating activities of (2,449.66) Lakhs, compared to (3,136.80) Lakhs in the previous year. Net cash inflows from investing activities amounted to 11.75 Lakhs, a significant reduction from 936.35 Lakhs recorded on March 31, 2025.
The company's key financial metrics, including the Cash and Cash Equivalents at the end of the year, showed a decline to 94.51 Lakhs on March 31, 2026, from 2,587.17 Lakhs on March 31, 2025.
NIRMAN Stock Price Movement
On Friday, Nirman Agri Genetics Limited shares slipped by 0.61% to settle at ₹48.8. The equity traded on a volume of 21,300 shares, ending the day below its previous close of ₹49.05.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: